title: Surgical outcome in thymic tumors with myasthenia gravis after plasmapheresis--a comparative study.
abstract: Plasmapheresis has been used widely in the treatment of myasthenia gravis and also in symptomatic thymectomized patients with short-term clinical improvement. But the utility of preoperative plasmapheresis in the outcome has not been widely studied. The authors analyzed its impact in the surgical outcome of thymic tumors with myasthenia gravis. We studied a total of 19 patients, who were operated on in the period from January 2000 to July 2006 for thymic tumors with myasthenia gravis. Of these 19 patients, preoperative plasmapheresis was performed in 10 patients (group B) and the remaining nine patients (group A) had no preoperative plasmapheresis based on risk factors for requirement of postoperative ventilation. Outcome in the form of requirement of ventilation, symptomatic improvement, hospital stay and requirement of drugs were assessed at the end of one year and compared between the two groups. Six out of nine patients (67%) in group A required ventilatory support in the immediate postoperative period, whereas two out of ten patients (20%) in group B required it. Significant and sustained symptomatic improvement was noted in group B as compared with group A (P<0.01). Preoperative plasmapheresis in the patients of thymic tumors with myasthenia gravis is beneficial and can cause a significant difference in the postoperative outcome.
authors.affiliation: Department of Cardio Thoracic and Vascular Surgery, Institute of Cardiovascular Sciences, Institute of Post Graduate Medical Education and Research, West Bengal, India. bappa_2k1_bk@yahoo.co.in
authors.forename: Binay Krishna
authors.initials: BK
authors.lastname: Sarkar
authors.forename: Pratim
authors.initials: P
authors.lastname: Sengupta
authors.forename: Uday Narayan
authors.initials: UN
authors.lastname: Sarkar
mesh_terms: D000328:Adult; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D010956:Plasmapheresis; D011300:Preoperative Care; D020127:Recovery of Function; D012121:Respiration, Artificial; D013256:Steroids / Q000627:therapeutic use; D013934:Thymectomy / Q000009:adverse effects; D013953:Thymus Neoplasms / Q000150:complications / Q000601:surgery / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D002800:Cholinesterase Inhibitors; D013256:Steroids